SANG vs LPSN vs NICE vs FIVN

For growth investors, Five9, Inc.

(FIVN) is the stronger pick with 10. 3% revenue growth year-over-year, versus -22. 0% for LivePerson, Inc. (LPSN). NICE Ltd. (NICE) offers the better valuation at 9. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate Sangoma Technologies Corporation (SANG) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, NICE Ltd.

(NICE) is the cheapest at 9. 9x versus Five9, Inc. at 48. 3x. On forward P/E, Five9, Inc. is actually cheaper at 7. 0x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Sangoma Technologies Corporation (SANG) delivered a total return of +25.

1%, compared to -99. 7% for LivePerson, Inc. (LPSN). Over 10 years, the gap is even starker: SANG returned +1995% versus LPSN's -97. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Sangoma Technologies Corporation (SANG) is the lower-risk stock at 0.

16β versus LivePerson, Inc. 's 2. 05β — meaning LPSN is approximately 1211% more volatile than SANG relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 108% for Five9, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Five9, Inc.

(FIVN) is pulling ahead at 10. 3% versus -22. 0% for LivePerson, Inc. (LPSN). On earnings-per-share growth, the picture is similar: Five9, Inc. grew EPS 370. 6% year-over-year, compared to 40. 5% for Sangoma Technologies Corporation. Over a 3-year CAGR, FIVN leads at 13. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

NICE Ltd.

(NICE) is the more profitable company, earning 20. 8% net margin versus -27. 6% for LivePerson, Inc. — meaning it keeps 20. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NICE leads at 21. 9% versus -9. 6% for LPSN. At the gross margin level — before operating expenses — NICE leads at 66. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Five9, Inc.

(FIVN) trades at 7. 0x forward P/E versus 8. 7x for NICE Ltd. — 1. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NICE: 57. 8% to $150. 88.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Sangoma Technologies Corporation (SANG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

16), +1995% 10Y return). LivePerson, Inc. (LPSN) carries a higher beta of 2. 05 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SANG: +1995%, LPSN: -97. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SANG is a small-cap quality compounder stock; LPSN is a small-cap quality compounder stock; NICE is a small-cap deep-value stock; FIVN is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.